NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the “Class Period”), of the February 21, 2025 lead plaintiff deadline in

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead

WASHINGTON, Jan. 14, 2025 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first individual I-526E petition approval for an investor in its Addison Row (JF32) project. An I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their eligible immediate family

EBC Financial Group earns high ratings across key areas, including a perfect 5.0 for deposit and withdrawal, and is committed to continuous improvement and innovation EBC Financial Group: Recognised Leader in FXEmpire’s 2025 Review LONDON, Jan. 13, 2025 (GLOBE NEWSWIRE) — EBC Financial Group (EBC), a leading global brokerage, has

Strategic Leadership Appointment Fuels Next Phase of Growth and Execution Following an Impressive 2024 Chris Kelly, president of go-to-market at Delinea Chris Kelly joins Delinea as President, Go-To-Market. SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Delinea, a pioneering provider of solutions for securing identities through centralized authorization, today announced

NEW YORK, Jan. 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff

NEW YORK, Jan. 11, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marqeta, Inc. (NASDAQ: MQ) between May 7, 2024 and November 4, 2024, both dates inclusive (the “Class Period”), of the important February 7, 2025 lead plaintiff deadline